$SCYX
SCYNEXIS, Inc.
XNAS•Health Care•Pharmaceutical Preparations
$3.73
▼-3.24%-$0.125
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateWhy is SCYX down today? It is at $3.73 (-3.24%), and our scanner flagged it 16 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment SCYX spikes, and full due diligence on SCYX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $SCYX 16 times in the last 30 days. Create a free account to track $SCYX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on SCYX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for SCYX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystClinical / FDA update, from the latest SEC filing. Read it →Across every filing on file, supply equal to at least 382.6% of the tradeable float is in play - 382.6% has already been sold.
Some filings did not state a size, so these are floors.
One filing exceeds the whole float, which usually means our share count is stale. Check the filing directly.
Recent share offering + active shelf on file — the company raised capital and can raise more
16,312,500 new shares (adjusted for the later reverse split) · Priced at $0.92/share
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Burke Steven Keith Director | Acquired (grant/award) | +6K 0.06% of company | n/a | 6K | n/a | Sep 18, 26 |
Hanham Ann Director | Acquired (grant/award) | +3K 0.03% of company | added 33% | 12K | n/a | Jun 26, 26 |
Hastings David C Director | Acquired (grant/award) | +3K 0.03% of company | added 33% | 12K | n/a | Jun 26, 26 |
Anido Armando Director | Acquired (grant/award) | +3K 0.03% of company | added 32% | 12K | n/a | Jun 26, 26 |
Macdonald Guy Director | Acquired (grant/award) | +3K 0.03% of company | added 29% | 13K | n/a | Jun 26, 26 |
Tinmouth Brian Philippe Director | Acquired (grant/award) | +3K 0.03% of company | added 31% | 12K | n/a | Jun 26, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on SCYX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for SCYX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
SCYX last traded at $3.73, down 3.24% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
SCYNEXIS, Inc. (SCYX) is next expected to report earnings on Wednesday, November 4, 2026, about 5 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The SCYX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged SCYX 16 times in the last 30 days.
SCYX (SCYNEXIS, Inc.) trades on XNAS, with a market cap of about $38M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge SCYX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$SCYX discussion
Sign in to ask a question or join the discussion.